Overview

Colon Staining Efficacy of Single Oral Doses of Methylene Blue MMX

Status:
Completed
Trial end date:
2012-01-16
Target enrollment:
Participant gender:
Summary
To describe and evaluate the mucosal staining efficacy of Methylene Blue MMX® tablets after total oral doses of 150 or 200 mg in patients undergoing a full colonoscopy for various reasons.
Phase:
Phase 2
Details
Lead Sponsor:
Cosmo Technologies Ltd
Collaborator:
Cross S.A.
Treatments:
Methylene Blue